• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唾液微生物组与胃食管反流病及其治疗。

Salivary microbiome with gastroesophageal reflux disease and treatment.

机构信息

Department of Periodontics, College of Dentistry, University of Illinois at Chicago, Chicago, IL, USA.

Department of Oral Medicine and Diagnostics, College of Dentistry, University of Illinois at Chicago, 801 South Paulina Street, Chicago, IL, 60612, USA.

出版信息

Sci Rep. 2021 Jan 8;11(1):188. doi: 10.1038/s41598-020-80170-y.

DOI:10.1038/s41598-020-80170-y
PMID:33420219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7794605/
Abstract

The effect of oral microbial composition on periodontal health and on systemic health has been, and is being established. The oral microbiome, in turn, can be altered by local and systemic diseases and conditions. Gastroesophageal reflux disease (GERD), has been associated with increased acidity in the oral cavity resulting in dental erosion, and controversially a reduced risk of periodontal disease. We hypothesized that presence of GERD was linked to a modified microbial profile in untreated GERD patients and that the use of proton pump inhibitor (PPI) drugs: potent disruptors of gut microbiome, in GERD patients might result in a salivary microbiome that is further distinct. Untreated GERD patients showed multiple differences in salivary microbiome as compared to healthy controls. Taxa found at lower levels related to the presence of GERD not treated by PPI included: Prevotella melaninogenica, Prevotella pallens, Leptotrichia, and Solobacterium moorei and thirteen others. In contrast, GERD patients chronically using PPI showed minimal differences in salivary taxa compared to healthy controls not using PPI.

摘要

口腔微生物组成对牙周健康和全身健康的影响已经得到证实。口腔微生物组反过来也可以被局部和全身疾病和状况所改变。胃食管反流病(GERD)与口腔内酸度增加有关,导致牙齿侵蚀,并且有争议的是牙周病的风险降低。我们假设 GERD 的存在与未经治疗的 GERD 患者的微生物特征改变有关,并且 GERD 患者使用质子泵抑制剂(PPI)药物——肠道微生物组的强效破坏剂——可能导致唾液微生物组进一步明显不同。与未经 PPI 治疗的 GERD 相关的低水平存在的分类群包括:普雷沃氏菌属黑色素原种、普雷沃氏菌属苍白亚种、勒特氏菌属和索氏梭杆菌,以及其他十三种。相比之下,长期使用 PPI 的 GERD 患者与未使用 PPI 的健康对照组相比,唾液分类群的差异最小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f9f/7794605/5ac621e6cb32/41598_2020_80170_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f9f/7794605/ab91bcc23bd6/41598_2020_80170_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f9f/7794605/e47043aba930/41598_2020_80170_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f9f/7794605/5ac621e6cb32/41598_2020_80170_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f9f/7794605/ab91bcc23bd6/41598_2020_80170_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f9f/7794605/e47043aba930/41598_2020_80170_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f9f/7794605/5ac621e6cb32/41598_2020_80170_Fig3_HTML.jpg

相似文献

1
Salivary microbiome with gastroesophageal reflux disease and treatment.唾液微生物组与胃食管反流病及其治疗。
Sci Rep. 2021 Jan 8;11(1):188. doi: 10.1038/s41598-020-80170-y.
2
The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study.质子泵抑制剂对胃食管反流婴儿粪便微生物组的影响:一项前瞻性纵向干预研究。
Front Cell Infect Microbiol. 2017 Oct 11;7:444. doi: 10.3389/fcimb.2017.00444. eCollection 2017.
3
Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease.质子泵抑制剂对胃食管反流病胃肠道微生物群的影响。
Genomics Proteomics Bioinformatics. 2019 Feb;17(1):52-63. doi: 10.1016/j.gpb.2018.12.004. Epub 2019 Apr 25.
4
Salivary microbiota composition before and after use of proton pump inhibitors in patients with laryngopharyngeal reflux: a self-control study.质子泵抑制剂治疗喉咽反流患者前后唾液微生物群组成的变化:一项自身对照研究。
BMC Oral Health. 2024 Oct 8;24(1):1194. doi: 10.1186/s12903-024-05000-3.
5
Comparison of the Microbiota and Inorganic Anion Content in the Saliva of Patients with Gastroesophageal Reflux Disease and Gastroesophageal Reflux Disease-Free Individuals.胃食管反流病患者和无胃食管反流病个体唾液微生物群和无机阴离子含量的比较。
Biomed Res Int. 2020 May 13;2020:2681791. doi: 10.1155/2020/2681791. eCollection 2020.
6
Clinical utility of salivary pepsin measurement in patients with proton pump inhibitor-refractory gastroesophageal reflux disease symptoms: a prospective comparative study.质子泵抑制剂抵抗性胃食管反流病症状患者唾液胃蛋白酶测量的临床实用性:一项前瞻性对照研究。
Esophagus. 2020 Jul;17(3):339-347. doi: 10.1007/s10388-020-00714-z. Epub 2020 Jan 25.
7
[The dental status of patients with gastroesophageal reflux disease depending on the intake of proton pump inhibitors].[根据质子泵抑制剂摄入量来看胃食管反流病患者的牙齿状况]
Stomatologiia (Mosk). 2020;99(5):25-31. doi: 10.17116/stomat20209905125.
8
ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?质子泵抑制剂治疗后持续出现症状是由于难治性胃食管反流病还是其他疾病?
Arq Gastroenterol. 2018 Nov;55Suppl 1(Suppl 1):85-91. doi: 10.1590/S0004-2803.201800000-48. Epub 2018 Oct 4.
9
Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis.使用质子泵抑制剂的胃食管反流病与骨质疏松症风险增加相关:一项基于全国人口的分析。
Osteoporos Int. 2016 Jun;27(6):2117-26. doi: 10.1007/s00198-016-3510-1. Epub 2016 Feb 10.
10
Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.质子泵抑制剂难治性胃食管反流病。
Med Clin North Am. 2019 Jan;103(1):15-27. doi: 10.1016/j.mcna.2018.08.002. Epub 2018 Nov 1.

引用本文的文献

1
Key Bacterial Taxa Differences Associated with Polypharmacy in Elderly Patients.老年患者中与多重用药相关的关键细菌类群差异
Microorganisms. 2025 Aug 12;13(8):1877. doi: 10.3390/microorganisms13081877.
2
The Oral-Gut Microbiota Axis Across the Lifespan: New Insights on a Forgotten Interaction.贯穿一生的口腔-肠道微生物群轴:对一种被遗忘的相互作用的新见解。
Nutrients. 2025 Aug 1;17(15):2538. doi: 10.3390/nu17152538.
3
Oral Microbiome Dysbiosis Is Associated With Precancerous Lesions and Disorders of Upper Gastrointestinal Tract: A Population-Based Study.

本文引用的文献

1
The salivary microbiota in health and disease.健康与疾病状态下的唾液微生物群
J Oral Microbiol. 2020 Feb 4;12(1):1723975. doi: 10.1080/20002297.2020.1723975. eCollection 2020.
2
Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data.使用 MicrobiomeAnalyst 进行微生物组数据的综合统计、功能和元分析。
Nat Protoc. 2020 Mar;15(3):799-821. doi: 10.1038/s41596-019-0264-1. Epub 2020 Jan 15.
3
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2.
口腔微生物群失调与上消化道癌前病变和疾病相关:一项基于人群的研究。
Am J Gastroenterol. 2024 Dec 31;120(9):2173-2185. doi: 10.14309/ajg.0000000000003279.
4
Proton Pump Inhibitors and Oral-Gut Microbiota: From Mechanism to Clinical Significance.质子泵抑制剂与口腔-肠道微生物群:从作用机制到临床意义
Biomedicines. 2024 Oct 7;12(10):2271. doi: 10.3390/biomedicines12102271.
5
Mechanistic Insights on Microbiota-Mediated Development and Progression of Esophageal Cancer.微生物群介导的食管癌发生发展机制的见解
Cancers (Basel). 2024 Sep 27;16(19):3305. doi: 10.3390/cancers16193305.
6
Salivary microbiota composition before and after use of proton pump inhibitors in patients with laryngopharyngeal reflux: a self-control study.质子泵抑制剂治疗喉咽反流患者前后唾液微生物群组成的变化:一项自身对照研究。
BMC Oral Health. 2024 Oct 8;24(1):1194. doi: 10.1186/s12903-024-05000-3.
7
Association between Oral Microbiome and Gastroesophageal Reflux Severity.口腔微生物群与胃食管反流严重程度之间的关联。
J Clin Med. 2024 Jul 31;13(15):4479. doi: 10.3390/jcm13154479.
8
Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BAD-BURN) in World Trade Center exposed firefighters: a case-control observational study protocol.气道疾病、巴雷特食管和未被诊断的反流的生物标志物在世界贸易中心暴露的消防员中的无创性评估(BAD-BURN):一项病例对照观察研究方案。
BMC Gastroenterol. 2024 Aug 9;24(1):255. doi: 10.1186/s12876-024-03294-9.
9
The oral microbiome and oral and upper gastrointestinal diseases.口腔微生物群与口腔及上消化道疾病
J Oral Microbiol. 2024 Jun 3;16(1):2355823. doi: 10.1080/20002297.2024.2355823. eCollection 2024.
10
Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BAD-BURN): a Case-Control Observational Study Protocol.气道疾病、巴雷特食管和未确诊反流的无创生物标志物(BAD-BURN):一项病例对照观察性研究方案
Res Sq. 2024 May 15:rs.3.rs-4355584. doi: 10.21203/rs.3.rs-4355584/v1.
使用QIIME 2进行可重复、交互式、可扩展和可延伸的微生物组数据科学研究。
Nat Biotechnol. 2019 Aug;37(8):852-857. doi: 10.1038/s41587-019-0209-9.
4
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.基于接受利伐沙班或阿司匹林的患者的大型多年随机试验的质子泵抑制剂安全性。
Gastroenterology. 2019 Sep;157(3):682-691.e2. doi: 10.1053/j.gastro.2019.05.056. Epub 2019 May 29.
5
The risks of long-term use of proton pump inhibitors: a critical review.长期使用质子泵抑制剂的风险:一项批判性综述。
Ther Adv Drug Saf. 2018 Nov 19;10:2042098618809927. doi: 10.1177/2042098618809927. eCollection 2019.
6
Subgingival microbiome in Chinese patients with generalized aggressive periodontitis compared to healthy controls.与健康对照相比,中国广泛性侵袭性牙周炎患者的龈下微生物组。
Arch Oral Biol. 2019 May;101:92-99. doi: 10.1016/j.archoralbio.2019.02.012. Epub 2019 Mar 4.
7
Gastroesophageal Reflux Disease: Pathophysiology, Diagnosis, and Treatment.胃食管反流病:病理生理学、诊断与治疗
Gastroenterol Nurs. 2019 Jan/Feb;42(1):20-28. doi: 10.1097/SGA.0000000000000359.
8
Diversity of the oral microbiome between dentate and edentulous individuals.有牙颌个体与无牙颌个体口腔微生物组的多样性。
Oral Dis. 2019 Apr;25(3):911-918. doi: 10.1111/odi.13039. Epub 2019 Feb 10.
9
Changes in the distal esophageal microbiota in Chinese patients with reflux esophagitis.中国反流性食管炎患者远端食管微生物群的变化。
J Dig Dis. 2019 Jan;20(1):18-24. doi: 10.1111/1751-2980.12692. Epub 2018 Dec 27.
10
The Oral Microbiota Is Modified by Systemic Diseases.口腔微生物群受全身性疾病影响而改变。
J Dent Res. 2019 Feb;98(2):148-156. doi: 10.1177/0022034518805739. Epub 2018 Oct 25.